Concepedia

Ana Martins

AM

8

Publications

345

Citations

8

H-Index

2013

Active since

Affiliations

Bielefeld University(Current)

IRBM Science Park

RINA Consulting - Centro Sviluppo Materiali S.p.A. (Italy)

Centro Hospitalar de Lisboa Ocidental

University of Milan

Ana Martins is an author at Bielefeld University specializing in tumor biology, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2013–2022

8

Publications

8

A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Vadim Le Joncour, Ana Martins, Maija Puhka et al. · Molecular Cancer Therapeutics · 2019 · 84 citations · Full text

ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer

Márk Barok, Vadim Le Joncour, Ana Martins et al. · Cancer Letters · 2020 · 77 citations · Full text

, , +11

Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer

Fatima Regina Abreu Alves, Lúcia Gil, Leonor Vasconcelos de Matos et al. · Cureus · 2022 · 46 citations · Full text

Synthesis and Biological Evaluation of RGD and <i>iso</i>DGR–Monomethyl Auristatin Conjugates Targeting Integrin α<sub>V</sub>β<sub>3</sub>

André Raposo Moreira Dias, Lizeth Bodero, Ana Martins et al. · ChemMedChem · 2019 · 35 citations · Full text

Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery

Adina Borbély, Eduard Figueras, Ana Martins et al. · Pharmaceutics · 2019 · 34 citations · Full text

Rows per page

1–5 of 8